ANAVEX LIFE SCIENCES CORP. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Anavex Life Sciences Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2024.
  • Anavex Life Sciences Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 84.5M shares, a 4.53% increase year-over-year.
  • Anavex Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 79.8M shares, a 3.74% increase from 2022.
  • Anavex Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 76.9M shares, a 10.2% increase from 2021.
  • Anavex Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 69.8M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 84.5M +3.66M +4.53% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 82.5M +4.16M +5.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 82.1M +4.1M +5.26% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 79.8M Jul 1, 2023 Sep 30, 2023 10-K 2023-11-27
Q2 2023 80.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 78.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 78M Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q1 2017 41.2M +5.94M +16.9% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 38.4M +4.42M +13% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-07
Q3 2016 35.2M +16.6M +89.2% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-14
Q2 2016 35.7M +16.6M +87% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-11
Q1 2016 35.2M +20.9M +146% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 34M +21.1M +163% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
Q3 2015 18.6M +8.78M +89.6% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-14
Q2 2015 19.1M -20.2M -51.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 14.3M -23.6M -62.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 12.9M -31M -70.6% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 9.8M -22.1M -69.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 39.3M +9.02M +29.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 37.9M +7.64M +25.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 43.9M +13.7M +45.3% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 31.9M +3.74M +13.3% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-29
Q2 2013 30.2M +1.89M +6.65% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 30.2M +2.9M +10.6% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-30
Q4 2012 30.2M +3.5M +13.1% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 28.2M +3M +11.9% Jul 1, 2012 Sep 30, 2012 10-K 2013-12-30
Q2 2012 28.4M +3.06M +12.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 27.3M +2.18M +8.65% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-17
Q4 2011 26.7M +2.47M +10.2% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 25.2M Jul 1, 2011 Sep 30, 2011 10-K 2012-12-31
Q2 2011 25.3M +4.13M +19.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-17
Q1 2011 25.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 24.3M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q2 2010 21.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.